trihexyphenidyl has been researched along with Cervical Dystonia in 20 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
Cervical Dystonia: A common form of DYSTONIA due to involuntary sustained or spasmodic, repetitive muscle contractions in the neck region. According to the position of the twisted neck and head, cervical dystonia can be categorized as torticollis, laterocollis, retrocollis, and a combination of these abnormal postures.
| Excerpt | Relevance | Reference |
|---|---|---|
| "An electromyographic method was used to study the effect of combination therapy with L-dopa and trihexyphenidyl on tremor in thirty patients suffering from extrapyramidal motor system disease." | 7.66 | Combination therapy of extrapyramidal disease with trihexyphenidyl and L-dopa: an electromyographic study with specific reference to tremor. ( Hökendorf, H, 1979) |
| "A total of 15 patients affected by idiopathic dystonia (7 with generalized and 8 with focal or segmental dystonia) were subjected to therapy with bromocriptine at low doses, pimozide and trihexyphenidyl." | 3.66 | Idiopathic dystonia: neuropharmacological study. ( Angelini, L; Broggi, G; Caraceni, T; Giovannini, P; Girotti, F; Nardocci, N; Scigliano, G, 1982) |
| "An electromyographic method was used to study the effect of combination therapy with L-dopa and trihexyphenidyl on tremor in thirty patients suffering from extrapyramidal motor system disease." | 3.66 | Combination therapy of extrapyramidal disease with trihexyphenidyl and L-dopa: an electromyographic study with specific reference to tremor. ( Hökendorf, H, 1979) |
| "A total of 105 patients with cervical dystonia were selected and randomly divided into medication treatment group (A group), botulinum toxin treatment group under the guidance of ultrasound treatment (B group) and botulinum toxin under the guidance of ultrasound treatment combined with orthopedic joint brace treatment group (C group)." | 2.80 | Efficacy analysis of ultrasound-guided local injection of botulinum toxin type A treatment with orthopedic joint brace in patients with cervical dystonia. ( Chen, HX; Ding, XD; Huang, L; Wang, H; Wang, W; Xiao, HQ, 2015) |
| " We found no information on a dose-response relationship with BtA, differences between BtA formulations or different anticholinergics, the utility of electromyography-guided injections, or the duration of treatment effect." | 2.72 | Botulinum toxin type A versus anticholinergics for cervical dystonia. ( Castelão, M; Costa, J; Duarte, GS; Ferreira, J; Marques, RE; Moore, AP; Rodrigues, FB; Sampaio, C, 2021) |
| " Oral administration of high dosage of anticholinergic drugs is firstly recommended for the treatment of dystonia." | 2.41 | [Medical treatment of dystonia]. ( Kachi, T, 2001) |
| "Spasmodic torticollis is classified as a focal dystonia." | 2.38 | [Therapeutic possibilities in spasmodic torticollis]. ( Auff, E; Deecke, L; Wöber, C, 1991) |
| "To determine whether patients with cervical dystonia have electrophysiological signs of disinhibition in the somatosensory cortex by recording high-frequency oscillations (HFOs) in somatosensory evoked potentials (SEPs)." | 1.32 | Disinhibition of the somatosensory cortex in cervical dystonia-decreased amplitudes of high-frequency oscillations. ( Hashimoto, I; Inoue, K; Kawakami, H; Matsumoto, M; Mimori, Y; Miyachi, T; Shirai, T, 2004) |
| "Three patients who had adult-onset dystonia and who were exhibiting respiratory problems were examined clinically and electrophysiologically." | 1.29 | Involvement of respiratory muscles in adult-onset dystonia: a clinical and electrophysiological study. ( Bergouignan, FX; Burbaud, P; Ferrer, X; Julien, J; Lagueny, A; Le Masson, G, 1995) |
| "Clonic torticollis were less frequently associated to pain." | 1.28 | [Craniocervical dystonia and facial hemispasm: clinical and pharmacological characteristics of 52 patients]. ( Astarloa, R; de Yébenes, JG; Morales, B; Peñafiel, N; Rábano, J, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (40.00) | 18.7374 |
| 1990's | 3 (15.00) | 18.2507 |
| 2000's | 5 (25.00) | 29.6817 |
| 2010's | 3 (15.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rodrigues, FB | 1 |
| Duarte, GS | 1 |
| Castelão, M | 1 |
| Marques, RE | 1 |
| Ferreira, J | 1 |
| Sampaio, C | 1 |
| Moore, AP | 1 |
| Costa, J | 1 |
| Burciu, RG | 1 |
| Hess, CW | 1 |
| Coombes, SA | 1 |
| Ofori, E | 1 |
| Shukla, P | 1 |
| Chung, JW | 1 |
| McFarland, NR | 1 |
| Wagle Shukla, A | 1 |
| Okun, MS | 1 |
| Vaillancourt, DE | 1 |
| Huang, L | 1 |
| Chen, HX | 1 |
| Ding, XD | 1 |
| Xiao, HQ | 1 |
| Wang, W | 1 |
| Wang, H | 1 |
| Patel, S | 1 |
| Martino, D | 1 |
| Kachi, T | 1 |
| Inoue, K | 1 |
| Hashimoto, I | 1 |
| Shirai, T | 1 |
| Kawakami, H | 1 |
| Miyachi, T | 1 |
| Mimori, Y | 1 |
| Matsumoto, M | 1 |
| Tey, HL | 1 |
| Seet, RC | 1 |
| Lim, EC | 1 |
| Desarkar, P | 1 |
| Thakur, A | 1 |
| Sinha, VK | 1 |
| Girotti, F | 1 |
| Scigliano, G | 1 |
| Nardocci, N | 1 |
| Angelini, L | 1 |
| Broggi, G | 1 |
| Giovannini, P | 1 |
| Caraceni, T | 1 |
| Marsden, CD | 1 |
| Marion, MH | 1 |
| Quinn, N | 1 |
| Lagueny, A | 1 |
| Burbaud, P | 1 |
| Le Masson, G | 1 |
| Bergouignan, FX | 1 |
| Ferrer, X | 1 |
| Julien, J | 1 |
| DiMario, FJ | 1 |
| Hökendorf, H | 1 |
| Astarloa, R | 1 |
| Morales, B | 1 |
| Peñafiel, N | 1 |
| Rábano, J | 1 |
| de Yébenes, JG | 1 |
| Wöber, C | 1 |
| Auff, E | 1 |
| Deecke, L | 1 |
| Trend, P | 1 |
| Trimble, M | 1 |
| Wessely, S | 1 |
| Besson, JA | 1 |
| Ebmeier, KP | 1 |
| Gemmell, HG | 1 |
| Sharp, PF | 1 |
| McFadyen, M | 1 |
| Smith, FW | 1 |
| Boyson, SJ | 1 |
| Scherokman, B | 1 |
| Jabbari, B | 1 |
| Gunderson, CH | 1 |
| Miller, JM | 1 |
| Rappaport, HL | 1 |
| Wolf, SM | 1 |
4 reviews available for trihexyphenidyl and Cervical Dystonia
| Article | Year |
|---|---|
Botulinum toxin type A versus anticholinergics for cervical dystonia.
Topics: Botulinum Toxins, Type A; Humans; Muscarinic Antagonists; Neuromuscular Agents; Torticollis; Trihexy | 2021 |
Cervical dystonia: from pathophysiology to pharmacotherapy.
Topics: Botulinum Toxins; Botulinum Toxins, Type A; Humans; Muscarinic Antagonists; Neuromuscular Agents; To | 2013 |
[Medical treatment of dystonia].
Topics: Cholinergic Antagonists; Clonazepam; Diazepam; Dopamine Antagonists; Dystonia; Humans; Levodopa; Tor | 2001 |
[Therapeutic possibilities in spasmodic torticollis].
Topics: Accessory Nerve; Biofeedback, Psychology; Botulinum Toxins; Humans; Spinal Nerve Roots; Torticollis; | 1991 |
2 trials available for trihexyphenidyl and Cervical Dystonia
| Article | Year |
|---|---|
Efficacy analysis of ultrasound-guided local injection of botulinum toxin type A treatment with orthopedic joint brace in patients with cervical dystonia.
Topics: Administration, Oral; Adult; Baclofen; Botulinum Toxins, Type A; Braces; Carbamazepine; Cross-Sectio | 2015 |
Trihexyphenidyl and torticollis.
Topics: Adult; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Male; Middle Aged; To | 1986 |
14 other studies available for trihexyphenidyl and Cervical Dystonia
| Article | Year |
|---|---|
Functional activity of the sensorimotor cortex and cerebellum relates to cervical dystonia symptoms.
Topics: Anti-Dyskinesia Agents; Botulinum Toxins; Brain Mapping; Cerebellum; Cohort Studies; Female; Humans; | 2017 |
Disinhibition of the somatosensory cortex in cervical dystonia-decreased amplitudes of high-frequency oscillations.
Topics: Adult; Aged; Case-Control Studies; Dominance, Cerebral; Evoked Potentials, Somatosensory; Female; Hu | 2004 |
Tuberculomas causing cervical dystonia.
Topics: Adult; Antiparkinson Agents; Antitubercular Agents; Humans; Magnetic Resonance Imaging; Male; Tortic | 2005 |
Aripiprazole-induced acute dystonia.
Topics: Acute Disease; Adolescent; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Dystonia; Humans; M | 2006 |
Idiopathic dystonia: neuropharmacological study.
Topics: Adolescent; Adult; Aged; Bromocriptine; Dystonia; Female; Humans; Male; Middle Aged; Pimozide; Syndr | 1982 |
The treatment of severe dystonia in children and adults.
Topics: Adolescent; Adult; Age Factors; Child; Drug Therapy, Combination; Dystonia Musculorum Deformans; Fem | 1984 |
Involvement of respiratory muscles in adult-onset dystonia: a clinical and electrophysiological study.
Topics: Administration, Oral; Aged; Baclofen; Botulinum Toxins; Delayed-Action Preparations; Diaphragm; Dyst | 1995 |
Childhood head tremor.
Topics: Child; Child, Preschool; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant; Male; | 2000 |
Combination therapy of extrapyramidal disease with trihexyphenidyl and L-dopa: an electromyographic study with specific reference to tremor.
Topics: Aged; Basal Ganglia Diseases; Drug Therapy, Combination; Electromyography; Female; Humans; Levodopa; | 1979 |
[Craniocervical dystonia and facial hemispasm: clinical and pharmacological characteristics of 52 patients].
Topics: Adolescent; Adult; Aged; Blepharospasm; Clonazepam; Facial Nerve Diseases; Female; Humans; Male; Mid | 1991 |
Schizophrenic psychosis associated with benzhexol (artane) therapy.
Topics: Adult; Female; Humans; Schizophrenia; Torticollis; Trihexyphenidyl | 1989 |
Brain imaging and treatment response in spasmodic torticollis.
Topics: Adult; Brain; Humans; Male; Spasm; Tomography, Emission-Computed; Torticollis; Trihexyphenidyl | 1988 |
Bethanechol for anticholinergic side effects.
Topics: Adult; Bethanechol Compounds; Female; Humans; Torticollis; Trihexyphenidyl | 1988 |
Reserpine: cause and treatment of oral-facial dyskinesia.
Topics: Deglutition Disorders; Diazepam; Face; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged | 1973 |